At a glance
ClinicalIndex Comparison RecordN/ACompleted· 424 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genotyping K-RAS and EGFR in Greek Non-small-cell Lung Cancer Patients: Incidence, Significance and Treatment Implications
In Brief
An observational study for Non Small Cell Lung Cancer. Completed, enrolled 424 participants across 1 site.
Detailed Summary
Retrospective analysis where patients with histologically confirmed Non-small cell lung cancer (NSCLC) were centrally evaluated for the presence of KRAS and EGFR mutations.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon Small Cell Lung Cancer
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2000
Primary CompletionDec 2012
Study CompletionDec 2014
First PostedMay 2019
TodayJul 2026
First PostedMay 15, 2019
Enrollment StartMar 1, 2000
Primary CompletionDec 1, 2012
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 12.8 yearsPosted 7.1 years ago